ANTX
AN2 Therapeutics Inc
4.40$
-6.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +2.9% | +6.9% | -4.8% | -16.2% | -6.4% | +15.0% | -2.4% | -59.9% | +74.8% | +4.3% | -33.4% | – | |
| – | -132.4% | – | – | – | – | -252.4% | – | – | -8.2% | -256.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +6,159.5% | -37.4% | +13.7% | -136.8% | – | -36.5% | +4.7% | +17.4% | +15.6% | -144.1% | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -100.5% | – | -100.0% | – | -100.0% | – | -100.0% | – | -100.0% | – | -96.0% | – | |
| – | – | – | -77.1% | +224.4% | -280.4% | – | – | – | – | +1,631.0% | -127.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.